Roberts Glore & CO Inc Cybin Inc. Transaction History
Roberts Glore & CO Inc
- $328 Million
- Q2 2024
A detailed history of Roberts Glore & CO Inc transactions in Cybin Inc. stock. As of the latest transaction made, Roberts Glore & CO Inc holds 10,000 shares of CYBN stock, worth $2,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$2,100
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CYBN
# of Institutions
102Shares Held
270MCall Options Held
0Put Options Held
0-
Deep Track Capital, LP Greenwich, CT58.1MShares$12.2 Million0.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA44MShares$9.24 Million0.18% of portfolio
-
Logos Global Management LP San Francisco, CA40MShares$8.4 Million1.01% of portfolio
-
Avidity Partners Management LP Dallas, TX34.9MShares$7.33 Million0.46% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L325.6MShares$5.37 Million1.01% of portfolio
About CYBIN INC.
- Ticker CYBN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 166,120,000
- Market Cap $34.9M
- Description
- Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...